tiprankstipranks
Immucell Corp. (ICCC)
NASDAQ:ICCC
US Market

Immucell (ICCC) Income Statement

Compare
74 Followers

Immucell Income Statement

Last quarter (Q3 2024), Immucell's total revenue was $6.01B, an increase of 111297.63% from the same quarter last year. In Q3, Immucell's net income was $-701.69M. See Immucell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 17.47M$ 18.57M$ 19.24M$ 15.34M$ 13.72M
Gross Profit
$ 4.40M$ 7.65M$ 8.66M$ 6.86M$ 6.74M
Operating Expenses
$ 10.14M$ 9.95M$ 8.40M$ 8.24M$ 7.69M
Depreciation and Amortization
$ 2.72M$ 2.49M$ 2.47M$ 2.36M$ 2.27M
EBITDA
$ -2.50M$ 349.99K$ 2.72M$ 1.65M$ 1.43M
Operating Income
$ -5.75M$ -2.30M$ -2.20M$ -1.38M$ -954.00K
Other Income/Expenses
$ -21.89K$ -187.19K$ -326.51K$ 348.10K$ -313.50K
Pretax Income
$ -5.77M$ -2.49M$ -69.00K$ -1.03M$ -1.27M
Net Income
$ -5.77M$ -2.49M$ -78.00K$ -1.02M$ -1.30M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.75$ -0.32$ -0.01$ -0.14$ -0.19
Diluted EPS
$ -0.75$ -0.32$ -0.01$ -0.14$ -0.19
Weighted Average Shares Outstanding
7.70M 7.75M 7.59M 7.21M 6.82M
Weighted Average Shares Outstanding (Diluted)
7.75M 7.75M 7.59M 7.21M 6.82M
Currency in USD

Immucell Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis